266 related articles for article (PubMed ID: 26831335)
21. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
22. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
Marras C; Alcalay RN; Caspell-Garcia C; Coffey C; Chan P; Duda JE; Facheris MF; Fernández-Santiago R; Ruíz-Martínez J; Mestre T; Saunders-Pullman R; Pont-Sunyer C; Tolosa E; Waro B;
Mov Disord; 2016 Aug; 31(8):1192-202. PubMed ID: 27091104
[TBL] [Abstract][Full Text] [Related]
23. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson's disease patients.
Li J; Zhang Y; Li Y
Br J Neurosurg; 2015 Jun; 29(3):329-33. PubMed ID: 25812021
[TBL] [Abstract][Full Text] [Related]
25. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
[TBL] [Abstract][Full Text] [Related]
26. Fusion image-based programming after subthalamic nucleus deep brain stimulation.
Paek SH; Kim HJ; Yoon JY; Heo JH; Kim C; Kim MR; Lim YH; Kim KR; Kim JW; Han JH; Kim DG; Jeon BS
World Neurosurg; 2011; 75(3-4):517-24. PubMed ID: 21600506
[TBL] [Abstract][Full Text] [Related]
27. Short-term effect of bilateral subthalamic stimulation for advanced Parkinson's disease.
Chen CC; Lee ST; Wu T; Chen CJ; Chen MC; Lu CS
Chang Gung Med J; 2003 May; 26(5):344-51. PubMed ID: 12934851
[TBL] [Abstract][Full Text] [Related]
28. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
[TBL] [Abstract][Full Text] [Related]
29. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.
Somme JH; Molano Salazar A; Gonzalez A; Tijero B; Berganzo K; Lezcano E; Fernandez Martinez M; Zarranz JJ; Gómez-Esteban JC
Parkinsonism Relat Disord; 2015 May; 21(5):494-9. PubMed ID: 25840672
[TBL] [Abstract][Full Text] [Related]
30. G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.
Hashad DI; Abou-Zeid AA; Achmawy GA; Allah HM; Saad MA
Genet Test Mol Biomarkers; 2011 Dec; 15(12):861-6. PubMed ID: 21699405
[TBL] [Abstract][Full Text] [Related]
31. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
[TBL] [Abstract][Full Text] [Related]
32. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.
Alcalay RN; Mejia-Santana H; Mirelman A; Saunders-Pullman R; Raymond D; Palmese C; Caccappolo E; Ozelius L; Orr-Urtreger A; Clark L; Giladi N; Bressman S; Marder K;
Parkinsonism Relat Disord; 2015 Feb; 21(2):106-10. PubMed ID: 25434972
[TBL] [Abstract][Full Text] [Related]
33. Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.
Mirelman A; Heman T; Yasinovsky K; Thaler A; Gurevich T; Marder K; Bressman S; Bar-Shira A; Orr-Urtreger A; Giladi N; Hausdorff JM;
Mov Disord; 2013 Oct; 28(12):1683-90. PubMed ID: 24123150
[TBL] [Abstract][Full Text] [Related]
34. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
[TBL] [Abstract][Full Text] [Related]
35. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
[TBL] [Abstract][Full Text] [Related]
36. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.
Kleiner-Fisman G; Herzog J; Fisman DN; Tamma F; Lyons KE; Pahwa R; Lang AE; Deuschl G
Mov Disord; 2006 Jun; 21 Suppl 14():S290-304. PubMed ID: 16892449
[TBL] [Abstract][Full Text] [Related]
37. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
38. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation].
Furgała A; Górecka-Mazur A; Fiszer U; Pietraszko W; Thor P; Moskała M; Potasz K; Bukowczan M; Polak J; Krygowska-Wajs A
Przegl Lek; 2015; 72(5):246-52. PubMed ID: 26817327
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
